A Depressive Endophenotype of Mild Cognitive Impairment and Alzheimer's Disease

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Johnson, Leigh A ^a,b   Hall, James R ^a,b   O'Bryant, Sid E ^a,b  

^a University of North Texas Health Science Center   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DEPTH PERCEPTION; DISEASE ASSOCIATION; ENDOPHENOTYPE; EXECUTIVE FUNCTION; EXECUTIVE INTERVIEW; FEMALE; GERIATRIC DEPRESSION SCALE; GERIATRIC PATIENT; HUMAN; LANGUAGE ABILITY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT ASSESSMENT; REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS; RISK FACTOR; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION DISORDERS; DEPRESSION; DEPRESSIVE DISORDER; DISEASE PROGRESSION; ENDOPHENOTYPES; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; RISK; TEXAS;

EID: 84880065327     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068848     Document Type: Article

References (59)

1. Alzheimer's Association (2012) Alzheimer's Disease Facts and Figures. Alzheimers Dement 8: 1-72. doi:10.1016/S1552-5260(12)00093-3. PubMed: 22265587.
2. Alzheimer's Association (2008) 2008 Alzheimer's disease facts and figures. Alzheimers Dement 4: 110-133. doi:10.1016/j.jalz.2008.02.005. PubMed: 18631956.
3. Alzheimer's Association (2010) Changing the trajectory of Alzheimer's disease. Facts and Figures.
4. Gottesman II, Shields J, (1973) Genetic theorizing and schizophrenia. Bri J Psychiatry 122: 15-30. doi:10.1192/bjp.122.1.15. PubMed: 4683020.
5. Gottesman II, Gould TD, (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160: 636-645. doi:10.1176/appi.ajp.160.4.636. PubMed: 12668349.
6. O'Bryant SE, Waring SC, Hobson V, Hall JR, Moore CB, et al. (2010) Decreased C-reactive protein levels in alzheimer disease. J Geriatr Psychiatry Neurol 23: 49-53. doi:10.1177/0891988709351832. PubMed: 19933496.
7. O'Bryant SE, Xiao G, Barber R, Reisch J, Doody R, et al. (2010) A serum protein-based algorithm for the detection of Alzheimer disease. Arch Neurol 67: 1077-1081. doi:10.1001/archneurol.2010.215. PubMed: 20837851.
8. O'Bryant SE, Hobson VL, Hall JR, Barber RC, Zhang S, et al. (2010) Serum Brain-Derived Neurotrophic Factor Levels Are Specifically Associated with Memory Performance among Alzheimer's Disease Cases. Dement Geriatr Cogn Disord 31: 31-36. PubMed: 21135555.
9. Janocko NJ, Brodersen KA, Soto-Ortolaza AI, Ross OA, Liesinger AM, et al. (2012) Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia. Acta Neuropathol 124(5):: 681-692. doi:10.1007/s00401-012-1044-y. PubMed: 22968369.
10. Braskie MN, Ringman JM, Thompson PM, (2011) Neuroimaging measures as endophenotypes in Alzheimer's disease. Int J Alzheimers Dis(2011): pp. 490140:490140. PubMed: 21547229.
11. During EH, [!(surname)!], Elahi FM, Mosconi L, de Leon MJ, (2011) The concept of FDG-PET endophenotype in Alzheimer's disease. Neurol Sci 32: 559-569. doi:10.1007/s10072-011-0633-1. PubMed: 21630036.
12. Nilufer T, (2011) Gene expression endophenotypes: a novel approach for gene discovery in Alzheimer's disease. Mol Neurodeg 3: 1-14. PubMed: 21569597.
13. Cruchaga C, Kauwe J, Nowotny P, Bales K, Pickering EH, et al. (2012) Cerebrospinal fluit APOE levels: an endophenotype for genetic studies for Alzheimer's disease. Hum Mol Gene21 (20):4558-4571.
14. Panza F, Seripa D, D'Onofrio G, Frisardi V, Solfrizzi V, et al. (2011) Neuropsychiatric symptoms, endophenotypes and syndromes in late-onset Alzheimer's disease: Focus on APOE gene. Int J Alzheimers Dis,(2011) Article ID: 721457: 14 pages PubMed: 21559196.
15. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D, (2006) Depression and risk for Alzheimer disease: Systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 63: 530-538. doi:10.1001/archpsyc.63.5.530. PubMed: 16651510.
16. Bruce JM, Bhalla R, Westervelt HJ, Davis J, Williams V, et al. (2008) Neuropsychological correlates of self-reported depression and self-reported cognition among patients with mild cognitive impairment. J Geriatr Psychiatry Neurol 21: 34-40. doi:10.1177/0891988707311032. PubMed: 18287168.
17. Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K, (2006) Depressive symptoms, vascular disease, and mild cognitive impairment: Findings from the cardiovascular health study. Arch Gen Psychiatry 63: 273-280. doi:10.1001/archpsyc.63.3.273. PubMed: 16520432.
18. Modrego PJ, Ferrández J, (2004) Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: A prospective cohort study. Arch Neurol 61: 1290-1293. doi:10.1001/archneur.61.8.1290. PubMed: 15313849.
19. Hart RP, Kwentus JA, Taylor JR, Harkins SW, (1987) Rate of forgetting in dementia and depression. J Consult Clin Psychol 55: 101-105. doi:10.1037/0022-006X.55.1.101. PubMed: 3571646.
20. Baune BT, Suslow T, Engelien A, Arolt V, Berger K, (2006) The association between depressive mood and cognitive performance in an elderly general population- the MEMO Study. Dem Geriatr Cog Dis 22: 142-149. doi:10.1159/000093745.
21. Boone KB, Lesser IM, Miller BL, Wohl M, Berman N, et al. (1995) Cognitive functioning in older depressed outpatients: Relationship of presence and severity of depression to neuropsychological test scores. Neuropsychol 9: 390-398. doi:10.1037/0894-4105.9.3.390.
22. Kizilbash AH, Vanderploeg RD, Curtiss G, (2002) The effects of depression and anxiety on memory performance. Arch Clin Neuropsychol 17: 57-67. doi:10.1016/S0887-6177(00)00101-3. PubMed: 14589753.
23. Delano-Wood L, Houston WS, Emond JA, Marchant NL, Salmon DP, et al. (2008) APOE genotype predicts depression in women with Alzheimer's disease: A retrospective study. Int J Geriatr Psychiatry 23: 632-636. doi:10.1002/gps.1953. PubMed: 18058831.
24. Lyketsos CG, Steele C, Baker L, Galik E, Kopunek S, et al. (1997) Major and minor depression in Alzheimer's disease: Prevalence and impact. J Neuropsychiatry Clin Neurosci 9: 556-561. PubMed: 9447496.
25. González-Salvador T, Lyketsos CG, Baker A, Hovanec L, Roques C, et al. (2000) Quality of life in dementia patients in long-term care. Int J Geriatri Psychiatry 15: 181-189. doi:10.1002/(SICI)1099-1166(200002)15:2. PubMed: 10679850.
26. O'Bryant SE, Zhang Y, Owen D, Cherry B, Ramirez V, et al. (2009) The Cochran County Aging Study: Methodology and Descriptive Statistics. Texas: Public Health Journal 61: 5-7.
27. O'Bryant SE, Hall JR, Cukrowicz KC, Edwards M, Johnson LA, et al. (2011) The differential impact of depressive symptom clusters on cognition in a rural multi-ethnic cohort: A Project FRONTIER study. Int J Geriatri Psychiatry 26: 199-205. doi:10.1002/gps.2514.
28. O'Bryant SE, Edwards M, Menon CV, Gong G, Barber R, (2011) Long-term low-level arsenic exposure is associated with poorer neuropsychological functioning: A Project FRONTIER Study. Int J Environ Res Public Health 8: 861-874. doi:10.3390/ijerph8030861. PubMed: 21556183.
29. Gong G, Hargrave KA, Hobson V, Spallholz J, Boylan M, et al. (2011) Low-level groundwater arsenic exposure impacts cognition: A project FRONTIER study. J Environ Health 74: 16-22. PubMed: 21949980.
30. Johnson LA, Hobson V, Jenkins M, Dentino A, Michael Ragain R, et al. (2011) The influence of thyroid function on cognition in a sample of ethnically diverse, rural-dwelling women: A project frontier study. J Neuropsychiatry Clin Neurosci 23: 219-222. doi:10.1176/appi.neuropsych.23.2.219. PubMed: 21677255.
31. Johnson LA, Mauer C, Jahn D, Song M, Wyshywaniuk L, et al. (2013) Cognitive differences among depressed and non-depressed MCI participants: A Project FRONTIER study. Int J Geriatri Psychiatry 28(4):: 377-382. doi:10.1002/gps.3835. PubMed: 22653735.
32. O'Fallon LD, Dearry A, (2001) Commitment of the National Institute of Environmental Health Sciences to Community-Based Participatory Research for Rural Health. Environ Health Perspect 109: 469-473. doi:10.1289/ehp.01109s3469. PubMed: 11427398.
33. McKhann D, Drockman D, Katzman Folstein M R, Price D, et al (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group. Neurologist 34: 939-944.
34. Petersen RC, editor (2003) Mild Cognitive Impairment: Aging to Alzheimer's Disease. New York: Oxford University Press.
35. Ivnik R, Malec JF, Smith GE, Tangalos EG, Petersen RC, et al. (1992) Mayo's Older Americans Normative Studies: WAIS-R norms for age 56 to 97. Clin Neuropsychol 6: 1-30. doi:10.1080/13854049208404110.
36. O'Bryant SE, Waring SC, Cullum CM, Hall J, Lacritz L, et al. (2008) Staging dementia using clinical dementia rating scale sum of boxes scores: A Texas Alzheimer's Research Consortium study. Arch Neurol 65: 1091-1095. doi:10.1001/archneur.65.8.1091. PubMed: 18695059.
37. O'Bryant SE, Xiao G, Barber R, Reisch J, Hall J, et al. (2011) A blood-based algorithm for the detection of Alzheimer's disease. Dem Geriatri Cogn Dis 32: 55-62. doi:10.1159/000330750.
38. O'Bryant SE, Xiao G, Barber R, Huebinger R, Wilhelmsen K, et al. (2011) A Blood-Based Screening Tool for Alzheimer's Disease That Spans Serum and Plasma: Findings from TARC and ADNI. PLOS ONE 6: e28092. doi:10.1371/journal.pone.0028092. PubMed: 22163278.
39. Hall JR, Edwards M, Barber RC, Johnson LA, Gong G, et al. (2012) Higher groundwater selenium exposure is associated with better memory: A Project FRONTIER Study. Neurosci Med 3: 18-25. doi:10.4236/nm.2012.31004.
40. Hall JR, O'Bryant SE, Johnson LA, Barber RC, (2012) Depressive symptom clusters and neuropsychological performance in mild Alzheimer's disease and cognitively normal elderly. Depress Res Treat. doi:10.1155/2011/396958.
41. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, et al. (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dem 7: 263-269. doi:10.1016/j.jalz.2011.05.750. PubMed: 21514250.
42. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, et al. (1983) Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatri Res 17: 37-49.
43. Randolph C, (1998) Repeatable Battery for the Assessment of Neuropsychological Status: Manual. San Antonio: The Psychological Corporation.
44. Royall D, Mahurin RK, Gray K, (1992) Bedside assessment of executive cognitive impairment: The Executive Interview (EXIT). J AM Geriatri Soc 40: 1221-1226.
45. Duff K, Beglinger LJ, Schoenberg MR, Patton DE, Mold J, et al. (2005) Test-Retest Stability and Practice Effects of the RBANS in a Community Dwelling Elderly Sample. J Clin Exp Neuropsychol 27: 565-575. doi:10.1080/13803390490918363. PubMed: 16019633.
46. Duff K, Humphreys Clark JD, O'Bryant SE, Mold JW, Schiffer RB, et al. (2008) Utility of the RBANS in detecting cognitive impairment associated with Alzheimer's disease: Sensitivity, specificity, and positive and negative predictive powers. Arch Clin Neuropsychol 23: 603-612. doi:10.1016/j.acn.2008.06.004. PubMed: 18639437.
47. Stokholm J, Vogel A, Gade A, Waldemar G, (2005) The executive interview as a screening test for executive dysfunction in patients with mild dementia. J AM Geriatri Soc 53: 1577-1581. doi:10.1111/j.1532-5415.2005.53470.x. PubMed: 16137290.
48. Folstein MF, Folstein SE, McHugh PR, (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198. doi:10.1016/0022-3956(75)90026-6. PubMed: 1202204.
49. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL, (1982) A new clinical scale for the staging of dementia. Bri J Psychiatry 140: 566-572. doi:10.1192/bjp.140.6.566.
50. Steinberg BA, Bieliauskas LA, Smith GE, Ivnik RJ, (2005) Mayo's Older Americans Normative Studies: Age- and IQ-Adjusted Norms for the Trail-Making Test, the Stroop Test, and MAE Controlled Oral Word Association Test. Clin Neuropsychol 19: 329-377. doi:10.1080/13854040590945210. PubMed: 16120535.
51. Hobson VL, Hall JR, Harvey M, Cullum CM, Lacritz L, et al. (2011) An examination of the Boston Naming Test: Calculation of "estimated" 60-item score from 30-and 15-item scores in a cognitively impaired population. Int J Geriatri Psychiatry 26: 351-355. doi:10.1002/gps.2533.
52. Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, et al. (2007) Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur JNeurol 14: e1-e26. PubMed: 17222085.
53. Kennard M, (1998) Diagnostic markers for Alzheimer's disease. Neurobiol. Aging 19: 131-132.
54. Boustani M, Callahan CM, Unverzagt FW, Austrom MG, Perkins AJ, et al. (2005) Implementing a screening and diagnosis program for dementia in primary care. J Gen Intern Med 20: 572-577. doi:10.1007/s11606-005-0103-7. PubMed: 16050849.
55. Cotter VT, (2006) Alzheimer's disease: issues and challenges in primary care. Nurs Clin North Am 41: 83-93. doi:10.1016/j.cnur.2005.09.005. PubMed: 16492455.
56. Doody R, Ferris S, Salloway S, Meuser TM, Murthy A, et al. (2008) Inter-rater reliability between expert and nonexpert physicians in the diagnosis of amnestic MCI in the community setting. J AM Geriatri Soc 56(4):: 106.
57. Cirrito JR, Disabato BM, Restivo JL, Verges DK, Goebel WD, et al. (2011) Serotonin signaling is associated with lower amyloid-βlevels and plaques in transgenic mice and humans. Proc Natl Acad Sci U S A 108: 14968-14973. doi:10.1073/pnas.1107411108. PubMed: 21873225.
58. Hou Y, Aboukhatwa MA, Lei DL, Manaye K, Khan I, et al. (2010) Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice. Neuropharmacol 58: 911-920. doi:10.1016/j.neuropharm.2009.11.002. PubMed: 19917299.
59. Munro CA, Longmire CF, Drye LT, Martin BK, Frangakis CE, et al. (2012) Cognitive outcomes after sertaline treatment in patients with depression of alzheimer disease. Am J Geriatri Psychiatry 20(12):: 1036-1044. doi:10.1097/JGP.0b013e31826ce4c5. PubMed: 23032478.